Trump picks Dr. Marty Makary as Food and Drug Administration commissioner
President-elect Trump made a significant announcement on Friday, revealing his nomination of Dr. Marty Makary for the position of Food and Drug Administration (FDA) commissioner. In a statement, Trump expressed his pleasure in nominating Dr. Makary, emphasizing the need for a trusted leader to restore the American public’s confidence in the FDA. Trump highlighted Dr. Makary’s impressive credentials as a highly respected Johns Hopkins School of Medicine professor, surgical oncologist, and health policy expert.
This nomination follows Trump’s appointment of Robert F. Kennedy, Jr. to lead the Department of Health and Human Services with the goal of “Making America healthy again.” The President-elect aims to bring in top medical professionals to key positions within his administration to prioritize public health and well-being.
Dr. Makary’s role as FDA commissioner will involve collaborating with Robert F. Kennedy Jr. to address critical issues such as evaluating harmful chemicals in the food supply and ensuring the safety of drugs and biologics administered to the nation’s youth. Trump commended Dr. Makary for his membership in the National Academy of Medicine and his dedication to improving medical quality, reducing hospital and drug costs, and advocating for healthcare transparency.
Describing Dr. Makary as a pioneer in public health, cancer care, and surgery, Trump highlighted his numerous achievements, including receiving the Nobility in Science Award from the National Pancreas Foundation. Dr. Makary currently leads the Evidence-Based Medicine and Public Policy Research Group at Johns Hopkins, showcasing his commitment to evidence-based practices and healthcare policy advancement.
Trump expressed confidence in Dr. Makary’s ability to elevate the FDA to the gold standard of scientific research, streamline bureaucratic processes, and ensure that Americans have access to high-quality medical cures and treatments. The President-elect also announced other key appointments, including Dr. Janette Nesheiwat as surgeon general and Dr. Dave Weldon to lead the U.S. Centers for Disease Control and Prevention (CDC).
As the Trump administration transitions, these appointments signal a focus on healthcare excellence, scientific innovation, and public health priorities. By selecting top experts like Dr. Makary, the administration aims to address critical healthcare challenges and improve health outcomes for all Americans. The nomination of Dr. Makary for FDA commissioner underscores the administration’s commitment to ensuring the safety and efficacy of medical products and promoting public health initiatives.
